Reliance to manufacture Covid-19 vaccine; got drug regulator's approval

After its successful journey from oil to the internet to retail, India's biggest conglomerate Reliance has now stepped into manufacturing Covid-19 vaccines.

As per some reports, Reliance Life Sciences' application to conduct clinical trials of its two-dose Covid-19 vaccine got approval from the drug regulator on Thursday.

Phase 1 trials are usually conducted for 58 days, and once it is over Reliance could apply for Phase 2 and 3 trials.

Currently, there are six vaccines to have received emergency use authorisation. Serum Institute’s Covishield, Bharat Biotech's Covaxin, Russia’s Sputnik V, Moderna’s, Johnson & Johnson’s, and Cadila’s that was approved last week.

Also Watch: Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine